UnknownNot Applicable

The Clinical Significance of Sentinel Lymph Node Imaging Combined With Imaging Examination in Pelvic and Peritoneal Lymphadenectomy for Endometrial Carcinoma

60 participantsStarted 2022-04-01

Plain-language summary

The aim of this prospective cohort study is to explore the clinical significance of sentinel lymph node imaging combined imaging examination evaluation in pelvic and peritoneal lymphadenectomy for endometrial carcinoma management.

Who can participate

Age range10 Years – 90 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Females who are diagnosed with endometrial carcinoma;
✓. Patients who are willing to receive primary non-reserved fertility function surgery to treat their disease;
✓. Patients who are agreed to participated in this prospective cohort study.

Exclusion criteria

✕. Patients who still have the will to have pregnancy;
✕. Patients who have other diseases or heavy injuries that will interfere with the results;
✕. Simultaneous participation in another clinical study with investigational medicinal product(s) or researcher thinks the subjects are not suitable for this trial.

What they're measuring

the number (s) of pelvic and abdominal lymph node metastasis

Timeframe: 1 year during the perioperative period

the percentage (%) of pelvic and abdominal lymph node metastasis

Timeframe: 1 year during the perioperative period

the coincidence rate (%) of pelvic and abdominal lymph node imaging, sentinel lymph node imaging and pathological diagnosis

Timeframe: 1 year during the perioperative period

the effect of pelvic lymphadenectomy on the prognosis of endometrial carcinoma patients

Timeframe: 1 year during the perioperative period

Trial details

NCT IDNCT03877627

SponsorSecond Affiliated Hospital of Wenzhou Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-03-15

Contact for this trial

Yu ZHAO, Ph.D

13777760306 zhaoyu196035@163.com

View on ClinicalTrials.gov More Endometrial Carcinoma trials

Who can participate

Age range10 Years – 90 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Females who are diagnosed with endometrial carcinoma;
✓. Patients who are willing to receive primary non-reserved fertility function surgery to treat their disease;
✓. Patients who are agreed to participated in this prospective cohort study.

Exclusion criteria

✕. Patients who still have the will to have pregnancy;
✕. Patients who have other diseases or heavy injuries that will interfere with the results;
✕. Simultaneous participation in another clinical study with investigational medicinal product(s) or researcher thinks the subjects are not suitable for this trial.

What they're measuring

the number (s) of pelvic and abdominal lymph node metastasis

Timeframe: 1 year during the perioperative period

the percentage (%) of pelvic and abdominal lymph node metastasis

Timeframe: 1 year during the perioperative period

the coincidence rate (%) of pelvic and abdominal lymph node imaging, sentinel lymph node imaging and pathological diagnosis

Timeframe: 1 year during the perioperative period

the effect of pelvic lymphadenectomy on the prognosis of endometrial carcinoma patients

Timeframe: 1 year during the perioperative period